Simplex Trading, LLC My Md Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.22 - $0.58 $598 - $1,577	2,719 Added 118.27%	5,018 $1,000
Q3 2023 Nov 01, 2023	SELL	$0.47 - $1.87 $6,429 - $25,579	-13,679 Reduced 85.61%	2,299 $1,000
Q2 2023 Aug 04, 2023	SELL	$1.44 - $2.26 $120 - $189	-84 Reduced 0.52%	15,978 $23,000
Q1 2023 Apr 27, 2023	BUY	$1.1 - $2.86 $10,850 - $28,211	9,864 Added 159.15%	16,062 $27,000
Q4 2022 Feb 02, 2023	BUY	$0.92 - $96.0 $1,675 - $174,816	1,821 Added 41.6%	6,198 $7,000
Q3 2022 Nov 04, 2022	SELL	$2.22 - $82.2 $7,703 - $285,234	-3,470 Reduced 44.22%	4,377 $11,000
Q2 2022 Aug 03, 2022	BUY	$2.0 - $4.78 $4,642 - $11,094	2,321 Added 42.0%	7,847 $17,000
Q1 2022 May 02, 2022	SELL	$3.34 - $6.05 $9,716 - $17,599	-2,909 Reduced 34.49%	5,526 $25,000
Q4 2021 Feb 23, 2022	BUY	$5.46 - $9.69 $46,055 - $81,735	8,435 New	8,435 $51,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.